ubmslateNO-logo-ubm

NO Mobile Logo

Search form

Topics:

Sabinsa Cosmetics Granted Two New Ingredient Patents

Sabinsa Cosmetics Granted Two New Ingredient Patents

Photo © Shutterstock.com/goodluz

Sabinsa Cosmetics, a division of Sabinsa Corp. (East Windsor, NJ), announced that it has received two patents for novel cosmetic compositions in the U.S. and Europe. The formulations are based on what the company says is extensive research on combinations of Sabinsa’s branded ingredients. According to the company these patents are expected to “fuel the company’s rapid growth in the cosmetic industry” given increasing consumer demand for products like sunscreen lotions and hair growth formulations.

The U.S. patent (US 9498423) is for a combination of Sabinsa’s β – glucogallin (1-O-galloyl-β-D-glucose) or β – glucogallin and total gallates from amla (Sabinsa’s branded Saberry ingredient), concentrate of liquid endosperm of Cocos nucifera (Sabinsa’s branded Cococin ingredient) and the selenopeptides (γ-L-glutamyl-Se-methyl-L-selenocysteine, and γ-L-glutamyl-L-selenomethionine) “for maintaining the morphology and numbers of the dermal papilla cells when exposed to stress signals.” Specifically, the formulation is said to protect the dermal papilla cells from stressors like UVB radiation, and maintain the number of live dermal papilla cells at a level of 95% or higher when they are exposed to UVB radiation. The company notes that this composition has also received patents in Europe (EP2695603), Japan (JP6064274), New Zealand (NZ600307) and Russia (RU2606752).

The European patent (EP2461786) is for a hair growth formulation comprising β – glucogallin (1-O-galloyl-β-D-glucose) from amla (Saberry) and a concentrate of liquid endosperm of Cocos nucifera (Cococin). In addition to promoting healthy hair growth, the company says this formulation has also been shown to protect dermal papilla cells from UV rays. The composition also previously received an Australian patent (AU2010326651).

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.